| Literature DB >> 17956617 |
Manhai Long1, Bente Deutch, Eva C Bonefeld-Jorgensen.
Abstract
BACKGROUND: Human exposure to lipophilic persistent organic pollutants (POPs) including polychlorinated dibenzo-p-dioxins/furans (PCDDs/PCDFs), polychlorinated biphenyls (PCBs) and organochlorine pesticide is ubiquitous. The individual is exposed to a complex mixture of POPs being life-long beginning during critical developmental windows. Exposure to POPs elicits a number of species- and tissue-specific toxic responses, many of which involve the aryl hydrocarbon receptor (AhR). The aim of this study was to compare the actual level of integrated AhR transcriptional activity in the lipophilic serum fraction containing the actual POP mixture among Inuits from different districts in Greenland, and to evaluate whether the AhR transactivity is correlated to the bio-accumulated POPs and/or lifestyle factors.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17956617 PMCID: PMC2173889 DOI: 10.1186/1476-069X-6-32
Source DB: PubMed Journal: Environ Health ISSN: 1476-069X Impact factor: 5.984
Basic characteristics of study population
| Men | Nuuk | Sisimiut | Qaanaaq | Tasiilaq | All | |
| Age (years) | n | 50 | 52 | 43 | 41 | 186 |
| median | 54* | 30 | 34 | 34 | 37 | |
| mean | 54 | 31 | 34 | 34 | 39 | |
| min-max | 35–77 | 18–46 | 19–45 | 19–45 | 18–77 | |
| BMI (kg/m2) | n | 46 | 52 | 43 | 41 | 182 |
| median | 28 | 26 | 27 | 26 | 26 | |
| mean | 28 | 27 | 27 | 26 | 27 | |
| min-max | 22–35 | 19–36 | 20–41 | 21–33 | 19–41 | |
| Smoking (years) | n | 45 | 52 | 41 | 40 | 178 |
| median | 34* | 12 | 18 | 15 | 18 | |
| mean | 31 | 12 | 17 | 15 | 19 | |
| min-max | 0–59 | 0–26 | 0–31 | 0–31 | 0–59 | |
| n-3/n-6 | n | 50 | 37 | 43 | 41 | 171 |
| median | 0.61* | 0.22▲ | 0.40 | 0.40 | 0.40 | |
| mean | 0.74 | 0.29 | 0.48 | 0.45 | 0.50 | |
| min-max | 0.20–1.93 | 0.10–0.73 | 0.09–1.45 | 0.12–1.03 | 0.09–1.93 | |
| Seabird intake (per month) | n | 47 | 49 | 41 | na | 137 |
| median | 2.0* | 1.0 | 1.0 | na | 2.0 | |
| mean | 5.5 | 2.6 | 2.6 | na | 3.6 | |
| min-max | 0–20 | 0–28 | 0–20 | na | 0–28 | |
| Dairy food consumption (per month) | n | 48 | 51 | 43 | na | 142 |
| median | 41 | 51 | 32*♠ | na | 41 | |
| mean | 39 | 49 | 30 | na | 40 | |
| min-max | 2–84 | 8–84 | 3–58 | na | 2–84 | |
| Women | ||||||
| Age (years) | n | 45 | 42 | 36 | 48 | 171 |
| median | 38 | 31 | 34 | 29 | 34 | |
| mean | 36 | 33 | 33 | 30 | 33 | |
| min-max | 19–45 | 18–44 | 18–44 | 19–45 | 18–45 | |
| BMI (kg/m2) | n | 43 | 42 | 36 | 48 | 169 |
| median | 26 | 26 | 24 | 25 | 25 | |
| mean | 26 | 27 | 26 | 26 | 26 | |
| min-max | 18–32 | 19–47 | 18–34 | 17–40 | 17–47 | |
| Smoking (years) | n | 42 | 42 | 34 | 48 | 166 |
| median | 20 | 12 | 16 | 12 | 14 | |
| mean | 16 | 13 | 16 | 13 | 14 | |
| min-max | 0–33 | 0–27 | 0–29 | 0–31 | 0–33 | |
| n-3/n-6 | n | 45 | 38 | 36 | 48 | 167 |
| median | 0.25 | 0.29 | 0.40# | 0.41# | 0.33 | |
| mean | 0.29 | 0.32 | 0.48 | 0.46 | 0.38 | |
| min-max | 0.12–0.72 | 0.14–0.82 | 0.15–1.53 | 0.18–1.0 | 0.12–1.53 | |
| Seabird intake (per month) | n | 44 | 41 | 35 | na | 120 |
| median | 1.0 | 1.0 | 1.0 | na | 1.0 | |
| mean | 1.4 | 1.3 | 3.4 | na | 1.9 | |
| min-max | 0–8.0 | 0–2.0 | 1.0–28 | na | 0–28 | |
| Dairy food consumption (per month) | n | 45 | 42 | 35 | na | 122 |
| median | 56 | 57 | 37 | na | 49 | |
| mean | 53 | 49 | 36 | na | 47 | |
| min-max | 2–84 | 0–84 | 0–84 | na | 0–84 | |
| Men + Women | ||||||
| Age (years) | n | 95 | 94 | 79 | 89 | 357 |
| median | 44 | 31 | 34 | 32 | 35 | |
| mean | 46 | 31 | 33 | 32 | 36 | |
| min-max | 19–77 | 18–46 | 18–45 | 19–45 | 18–77 | |
| BMI (kg/m2) | n | 89 | 94 | 79 | 89 | 351 |
| median | 26 | 26 | 26 | 25 | 26 | |
| mean | 27 | 27 | 27 | 26 | 26 | |
| min-max | 18–35 | 19–47 | 18–41 | 17–40 | 17–47 | |
| Smoking (years) | n | 87 | 94 | 75 | 88 | 344 |
| median | 23 | 12 | 17 | 13 | 16 | |
| mean | 23 | 12 | 16 | 14 | 16 | |
| min-max | 0–59 | 0–27 | 0–31 | 0–31 | 0–59 | |
| n-3/n-6 | n | 95 | 75 | 79 | 89 | 338 |
| median | 0.36 | 0.25 | 0.40 | 0.40 | 0.36 | |
| mean | 0.51 | 0.30 | 0.48 | 0.45 | 0.44 | |
| min-max | 0.12–1.93 | 0.10–0.82 | 0.09–1.53 | 0.12–1.03 | 0.09–1.93 | |
| Seabird intake (per month) | n | 91 | 90 | 76 | na | 257 |
| median | 2.0 | 1.0 | 1.0 | na | 1.0 | |
| mean | 3.5 | 2.0 | 3.0 | na | 2.8 | |
| min-max | 0–20 | 0–28 | 0–28 | na | 0–28 | |
| Dairy food consumption (per month) | n | 93 | 93 | 78 | na | 264 |
| median | 48 | 51 | 36 | na | 43 | |
| mean | 46 | 49 | 33 | na | 43 | |
| min-max | 2–84 | 0–84 | 0–84 | na | 0–84 | |
na: not available.
*: p < 0.05 versus other districts; ▲: p < 0.05 versus Nuuk and Sisimiut men; #: p < 0.05 versus Nuuk and Sisimiut women; ♠: p < 0.05 versus Nuuk and Sisimiut men and all women.
The plasma POP levels in the subjects of the different district
| Men | Nuuk | Sisimiut | Qaanaaq | Tasiilaq | All | |
| Σ PCB_14 (μg/kg lipid) | n | 38 | 51 | 41 | 37 | 167 |
| median | 2682 | 540.9* | 1854 | 1890 | 1526 | |
| mean | 3094 | 752.1 | 2699 | 2079 | 2057 | |
| min-max | 490–11113 | 132–2366 | 617–7352 | 318–4527 | 132–11113 | |
| Σ pesticide (μg/kg lipid) | n | 38 | 51 | 41 | 41 | 171 |
| median | 3401 | 737.8* | 2630 | 2242 | 2126 | |
| mean | 4034 | 1012 | 3824 | 2372 | 2684 | |
| min-max | 405–19118 | 141–3542 | 617–14366 | 194–7224 | 141–19118 | |
| Σ POP (μg/kg lipid) | n | 38 | 51 | 41 | 37 | 167 |
| median | 6322 | 1353* | 4411 | 4067 | 3551 | |
| mean | 7127 | 1765 | 6524 | 4249 | 4692 | |
| min-max | 896–30231 | 285–5908 | 1234–19807 | 499–11260 | 285–30231 | |
| ΣDL-PCB/Σ PCB_14 (%) | n | 38 | 51 | 41 | 37 | 167 |
| median | 8.42♠ | 7.07 | 7.53 | 7.51 | 7.70 | |
| mean | 8.36 | 7.41 | 7.44 | 7.73 | 7.71 | |
| min-max | 5.0–11.0 | 4.0–11.0 | 4.0–11.0 | 6.0–11.0 | 4.0–11.0 | |
| Women | ||||||
| Σ PCB_14 (μg/kg lipid) | n | 44 | 42 | 34 | 47 | 167 |
| median | 295.7 | 346 | 1188▲ | 1660▲ | 635.5 | |
| mean | 492.4 | 459.7 | 1406 | 1809 | 1041 | |
| min-max | 97.5–2428 | 67.2–1384 | 99–5980 | 112–6701 | 67.2–6701 | |
| Σ pesticide (μg/kg lipid) | n | 44 | 42 | 34 | 48 | 168 |
| median | 481.6 | 496.3 | 1671▲ | 2044▲ | 860 | |
| mean | 678 | 700 | 2018 | 2397 | 1446 | |
| min-max | 83.6–2881 | 75.6–3014 | 77.9–7529 | 153–6995 | 85.5–7529 | |
| Σ POP (μg/kg lipid) | n | 44 | 42 | 34 | 47 | 167 |
| median | 748 | 823 | 2847▲ | 3797▲ | 1469 | |
| mean | 1171 | 1159 | 3424 | 4169 | 2480 | |
| min-max | 181–5309 | 143–4337 | 177–12432 | 256–12829 | 143–12829 | |
| ΣDL-PCB/Σ PCB_14 (%) | n | 44 | 42 | 34 | 47 | 167 |
| median | 9.01 | 9.26 | 8.45 | 8.96 | 9.00 | |
| mean | 9.02 | 9.40 | 8.78 | 9.02 | 9.10 | |
| min-max | 4.0–13.0 | 6.0–15.0 | 6.0–13.0 | 6.0–12.0 | 4.0–15.0 | |
| Men + Women | ||||||
| Σ PCB_14 (μg/kg lipid) | n | 82 | 93 | 75 | 84 | 334 |
| median | 912.4 | 495.3 | 1379# | 1806# | 1068 | |
| mean | 1698 | 620.0 | 2113 | 1928 | 1549 | |
| min-max | 97.5–11113 | 67.2–2366 | 99–7352 | 112–6701 | 67.2–11113 | |
| Σ pesticide (μg/kg lipid) | n | 82 | 93 | 75 | 89 | 339 |
| median | 1336 | 685.3 | 2156# | 2208# | 1327 | |
| mean | 2234 | 871 | 3006 | 2386 | 2071 | |
| min-max | 83.6–19118 | 75.6–3542 | 77.9–14366 | 153–7224 | 85.5–19118 | |
| Σ POP (μg/kg lipid) | n | 82 | 93 | 75 | 84 | 334 |
| median | 2322 | 1244 | 3437# | 4020# | 2420 | |
| mean | 3931 | 1491 | 5119 | 4206 | 3597 | |
| min-max | 181–30231 | 143–5908 | 177–19807 | 256–12829 | 143–30231 | |
| ΣDL-PCB/Σ PCB_14 (%) | n | 82 | 93 | 75 | 84 | 334 |
| median | 8.79 | 7.92 | 7.88 | 8.40 | 8.30 | |
| mean | 8.71 | 8.31 | 8.05 | 8.45 | 8.39 | |
| min-max | 4.0–13.0 | 4.0–15.0 | 4.0–13.0 | 6.0–12.0 | 4.0–15.0 | |
Σ PCB_14: sum of 14 PCB congeners; Σ pesticide: sum of 10 pesticides; Σ POP: Σ PCB_14 + Σ pesticide; ΣDL-PCBs: sum of dioxin-like PCBs (PCB105, PCB118, PCB156).
*: p < 0.05, versus men from other districts; ▲: p < 0.05, versus Nuuk and Sisimiut women;
#: p < 0.05, versus Nuuk and Sisimiut subjects; ♠: p < 0.05, versus men from other districts.
The serum levels of AhR transcriptional activity of subjects of the different district
| Men | Nuuk | Sisimiut | Qaanaaq | Tasiilaq | All | |
| AhR-TEQ1 (pg/g lipid) | n | 21 | 42 | 38 | 38 | 139 |
| median | 166 | 189 | 110* | 240 | 153 | |
| mean | 206 | 247 | 118 | 296 | 219 | |
| min-max | 95 – 1019 | 26 – 1202 | 58 – 271 | 98 – 1452 | 26 – 1452 | |
| % agonist | 79 | 88 | 100 | 97 | 91 | |
| AhRcomp2 (RLU/μg protein) | n | 38 | 51 | 43 | 38 | 170 |
| median | 0.78* | 1.21 | 1.35 | 1.04 | 1.15 | |
| mean | 0.82 | 1.24 | 1.38 | 1.12 | 1.15 | |
| min-max | 0.38 – 1.18 | 0.59 – 2.46 | 0.77 – 2.17 | 0.31 – 3.24 | 0.31 – 3.24 | |
| % increase | 0 | 44 | 54 | 29 | 33 | |
| % inhibition | 32 | 4 | 2 | 32 | 16 | |
| Women | ||||||
| AhR-TEQ1 (pg/g lipid) | n | 12 | 32 | 32 | 44 | 120 |
| median | 235 | 188 | 122* | 228 | 167 | |
| mean | 326 | 221 | 131 | 332 | 248 | |
| min-max | 115 – 1055 | 93 – 1032 | 63 – 259 | 100 – 1987 | 63 – 1987 | |
| % agonist | 64 | 64 | 100 | 91 | 79 | |
| AhRcomp2 (RLU/μg protein) | n | 45 | 42 | 36 | 44 | 167 |
| median | 1.41 | 1.33 | 1.31 | 1.28 | 1.32 | |
| mean | 1.50 | 1.38 | 1.33 | 1.92 | 1.54 | |
| min-max | 0.9 – 4.54 | 0.94 – 3.88 | 0.74 – 1.87 | 0.25 – 15 | 0.25 – 15 | |
| % increase | 49 | 64 | 58 | 46 | 54 | |
| % inhibition | 0 | 0 | 11 | 21 | 8 | |
| Men + Women | ||||||
| AhR-TEQ1 (pg/g lipid) | n | 33 | 74 | 70 | 82 | 259 |
| median | 188 | 189 | 115 | 239 | 161 | |
| mean | 250 | 236 | 124 | 315 | 232 | |
| min-max | 94 – 1055 | 26 – 1202 | 58 – 271 | 98 – 1987 | 26 – 1987 | |
| % agonist | 71 | 76 | 100 | 94 | 85 | |
| AhRcomp2 (RLU/μg protein) | n | 83 | 93 | 79 | 82 | 337 |
| median | 1.08 | 1.26 | 1.33 | 1.18 | 1.23 | |
| mean | 1.19 | 1.30 | 1.36 | 1.55 | 1.35 | |
| min-max | 0.38 – 4.54 | 0.59 – 3.88 | 0.74 – 2.17 | 0.25 – 15 | 0.25 – 15 | |
| % increase | 27 | 53 | 56 | 38 | 43 | |
| % inhibition | 15 | 2 | 6 | 26 | 12 | |
1AhR-TEQ (TCDD equivalents): The AhR-TEQ of samples eliciting significantly agonistic activity was calculated by interpolation to the TCDD dose-response curve using the Sigmaplot program, given as pg/g serum lipid. The % agonistic indicates the % of samples eliciting a significant increase in AhR activity compared to the solvent control. 2AhRcomp: AhR competitive activity of serum extract + 60 pM TCDD (EC50) given as RLU/μg protein. EC50 solvent control = 1 RLU/μg protein; % increase and % inhibition indicates the % of samples responding with a further increase or decrease of the EC50(TCDD) induced activity, respectively. *: p < 0.05 versus subjects from other districts.
Figure 1The serum AhR transcriptional activity. A) The AhR-TEQ in men from different districts; B) The AhR-TEQ in women from different districts; C) The AhRcomp activity in men from different districts and D) The AhRcomp activity in women from different districts. The reference line of the control is given as dash line (C, D). The values in the figure are percentage of sample with agonistic (A, B) and increase or inhibition of TCDD induced AhR transcriptional activity (C, D).
Multivate linear regression analysis of AhR-TEQ and POPs
| Nuuk | Sisimiut | Qaanaaq | Tasiilaq | All | ||||||||||||
| Mena | n | β | p | n | β | p | n | β | p | n | β | p | n | β | p | |
| raw1 | 21 | -.01 | .97 | 41 | -.24 | .13 | 37 | -.14 | .41 | 33 | -.06 | .72 | ||||
| +age | 21 | .05 | .86 | 41 | -.09 | .64 | 37 | .05 | .80 | 33 | .03 | .87 | 135 | -.16 | .11 | |
| +n-3/n-62 | 21 | -.01 | .98 | 29 | -.25 | .25 | 37 | -.30 | .23 | 33 | -.11 | .54 | 123 | -.22 | .07 | |
| +age+n-3/n-6 | 21 | .07 | .87 | 29 | -.06 | .81 | 37 | -.14 | .60 | 33 | .01 | .98 | 123 | -.16 | .21 | |
| raw | 21 | .08 | .72 | 41 | -.27 | .087 | 37 | -.20 | .23 | 37 | -.13 | .46 | ||||
| +age | 21 | .15 | .57 | 41 | -.14 | .44 | 37 | -.01 | .98 | 37 | -.05 | .78 | ||||
| +n-3/n-62 | 21 | .16 | .61 | 29 | -.34 | .13 | 37 | -.49 | .06 | 37 | -.20 | .23 | ||||
| +age+n-3/n-6 | 21 | .22 | .53 | 29 | -.20 | .39 | 37 | -.30 | .32 | 37 | -.09 | .60 | ||||
| raw1 | 21 | .04 | .86 | 41 | -.26 | .10 | 37 | -.19 | .24 | 33 | -.11 | .56 | ||||
| +age | 21 | .11 | .69 | 41 | -.12 | .50 | 37 | -.01 | .96 | 33 | -.02 | .93 | 135 | -.20 | .06 | |
| +n-3/n-62 | 21 | .09 | .78 | 29 | -.30 | .17 | 37 | -.48 | .07 | 33 | -.15 | .40 | ||||
| +age+n-3/n-6 | 21 | .16 | .66 | 29 | -.15 | .54 | 37 | -.29 | .31 | 33 | -.04 | .82 | 123 | -.23 | .06 | |
| Womenb | ||||||||||||||||
| raw1 | 12 | .06 | .85 | 32 | .23 | .20 | 43 | -.09 | .55 | 119 | -.04 | .70 | ||||
| +age | 12 | -.01 | .99 | 32 | .25 | .24 | 43 | -.21 | .35 | 119 | -.002 | .99 | ||||
| +n-3/n-62 | 12 | .58 | .19 | 28 | .17 | .43 | 32 | -.32 | .18 | 43 | -.13 | .50 | 115 | .06 | .62 | |
| +age+n-3/n-6 | 12 | .53 | .31 | 28 | .20 | .38 | 32 | -.25 | .36 | 43 | -.23 | .35 | 115 | .08 | .53 | |
| raw1 | 12 | .11 | .74 | 32 | .25 | .16 | 44 | -.11 | .46 | 120 | -.06 | .52 | ||||
| +age | 12 | .06 | .89 | 32 | .26 | .19 | 44 | -.28 | .20 | 120 | -.03 | .74 | ||||
| +n-3/n-62 | 12 | .69 | .12 | 28 | .19 | .39 | 44 | -.17 | .35 | 116 | .01 | .97 | ||||
| +age+n-3/n-6 | 12 | .65 | .20 | 28 | .20 | .37 | 32 | -.47 | .09 | 44 | -.31 | .19 | 116 | .02 | .89 | |
| raw1 | 12 | .09 | .79 | 32 | .24 | .18 | 43 | -.11 | .49 | 119 | -.05 | .57 | ||||
| +age | 12 | .03 | .95 | 32 | .25 | .22 | 43 | -.24 | .28 | 119 | -.02 | .83 | ||||
| +n-3/n-62 | 12 | .66 | .14 | 28 | .17 | .42 | 32 | -.47 | .07 | 43 | -.15 | .43 | 115 | .04 | .77 | |
| +age+n-3/n-6 | 12 | .62 | .23 | 28 | .20 | .39 | 32 | -.42 | .14 | 43 | -.27 | .27 | 115 | .05 | .67 | |
| Men + Womenc | ||||||||||||||||
| raw1 | 33 | -.19 | .29 | 74 | -.05 | .65 | 77 | -.10 | .40 | |||||||
| +age | 33 | -.09 | .79 | 74 | .03 | .83 | 77 | -.07 | .65 | 254 | -.10 | .18 | ||||
| +n-3/n-62 | 33 | .12 | .72 | 58 | -.15 | .30 | 77 | -.15 | .24 | 238 | -.16 | .06 | ||||
| +age+n-3/n-6 | 33 | .24 | .60 | 58 | -.09 | .53 | 70 | -.26 | .09 | 77 | -.11 | .49 | 238 | -.12 | .17 | |
| raw1 | 33 | -.13 | .47 | 74 | -.07 | .58 | 82 | -.12 | .28 | |||||||
| +age | 33 | .06 | .84 | 74 | .01 | .94 | 82 | -.12 | .38 | 254 | -.13 | .07 | ||||
| +n-3/n-62 | 33 | .29 | .37 | 58 | -.16 | .29 | 82 | -.21 | .09 | |||||||
| +age+n-3/n-6 | 33 | .41 | .29 | 58 | -.12 | .44 | 70 | 82 | -.17 | .22 | ||||||
| raw1 | 33 | -.16 | .38 | 74 | -.06 | .59 | 77 | -.12 | .30 | |||||||
| +age | 33 | -.001 | .997 | 74 | .01 | .92 | 77 | -.10 | .49 | 254 | -.12 | .09 | ||||
| +n-3/n-62 | 33 | .23 | .50 | 58 | .16 | .28 | 77 | -.18 | .17 | |||||||
| +age+n-3/n-6 | 33 | .36 | .395 | 58 | -.11 | .46 | 70 | 77 | -.14 | .36 | 238 | -.16 | .07 | |||
The analyses were performed on ln transformed data with AhR-TEQ as dependent and POPs as independent variables before and upon adjusted for the potential confounders.
1: non-adjusted data.
2: ratio of n-3 to n-6 fatty acids in serum.
a: Combining districts is not allowed according to the multiple regression analyses.
b: Combining districts is not allowed according to the multiple regression analyses.
c: According to the multiple regression analyses, combining sex for each district is allowed while combining sexes for all districts is not allowed.
For Σ PCB_14, Σ pesticide and Σ POP, AhR-TEQ, see the legend of Table 2 and Table 3
Multivate linear regression analysis of AhRcomp and POPs
| Nuuk | Sisimiut | Qaanaaq | Tasiilaq | All | ||||||||||||
| Mena | n | β | p | n | β | p | n | β | p | n | β | p | n | β | p | |
| raw1 | 38 | -.11 | .52 | 51 | -.13 | .36 | 41 | -.07 | .68 | 34 | -.18 | .31 | ||||
| +age | 38 | -.16 | .47 | 51 | -.03 | .87 | 41 | -.001 | 1.00 | 34 | -.29 | .15 | 164 | -.05 | .56 | |
| +n-3/n-62 | 38 | -.24 | .37 | 37 | .29 | .12 | 41 | .08 | .68 | 34 | -.20 | .27 | 150 | -.01 | .95 | |
| +age+n-3/n-6 | 38 | -.30 | .34 | 41 | .11 | .61 | 34 | -.29 | .15 | 150 | .10 | .35 | ||||
| raw1 | 38 | -.09 | .59 | 51 | -.20 | .17 | 41 | -.12 | .46 | 38 | -.27 | .11 | ||||
| +age | 38 | -.10 | .59 | 51 | -.12 | .45 | 41 | -.07 | .75 | 38 | -.36 | .05 | 168 | -.06 | .53 | |
| +n-3/n-62 | 38 | -.16 | .52 | 37 | .22 | .27 | 41 | .01 | .97 | 38 | -.29 | .10 | 154 | -.04 | .73 | |
| +age+n-3/n-6 | 38 | -.16 | .52 | 37 | .29 | .17 | 41 | .04 | .87 | 38 | -.36 | .06 | 154 | .07 | .49 | |
| raw1 | 38 | -.10 | .55 | 51 | -.18 | .22 | 41 | -.10 | .53 | 34 | -.19 | .28 | ||||
| +age | 38 | -.13 | .53 | 51 | -.09 | .57 | 41 | -.04 | .84 | 34 | -.30 | .13 | 164 | -.06 | .53 | |
| +n-3/n-62 | 38 | -.20 | .43 | 37 | .25 | .20 | 41 | .04 | .86 | 34 | -.21 | .25 | 150 | -.02 | .87 | |
| +age+n-3/n-6 | 38 | -.22 | .43 | 37 | .34 | .10 | 41 | .07 | .76 | 34 | -.30 | .13 | 150 | .09 | .46 | |
| Womenb | ||||||||||||||||
| raw1 | 44 | .08 | .60 | 42 | 17 | .28 | 34 | -.31 | .07 | 43 | -.18 | .24 | 163 | -.09 | .24 | |
| +age | 44 | .16 | .37 | 42 | .09 | .59 | 34 | -.15 | .46 | 163 | -.11 | .17 | ||||
| +n-3/n-62 | 44 | .18 | .25 | 38 | .09 | .62 | 34 | -.49 | .06 | 43 | -.27 | .14 | 159 | -.11 | .25 | |
| +age+n-3/n-6 | 44 | .25 | .14 | 38 | .07 | .71 | 34 | -.33 | .25 | 159 | -.13 | .21 | ||||
| raw1 | 44 | .07 | .67 | 42 | .09 | .57 | 34 | -.25 | .15 | 44 | -.21 | .18 | 164 | -.11 | .18 | |
| +age | 44 | .11 | .49 | 42 | .-.001 | .995 | 34 | -.07 | .72 | 164 | -.13 | .13 | ||||
| +n-3/n-62 | 44 | .18 | .26 | 38 | -.03 | .85 | 34 | -.37 | .17 | 44 | -.30 | .10 | 160 | -.14 | .18 | |
| +age+n-3/n-6 | 44 | .22 | .19 | 38 | -.06 | .76 | 34 | -.19 | .52 | 160 | -.15 | .15 | ||||
| raw1 | 44 | .08 | .62 | 42 | .12 | .45 | 34 | -.27 | .12 | 43 | -.195 | .21 | 163 | -.10 | .21 | |
| +age | 44 | .14 | .42 | 42 | .03 | .85 | 34 | -.10 | .64 | 163 | -.12 | .15 | ||||
| +n-3/n-62 | 44 | .19 | .24 | 38 | .01 | .97 | 34 | -.42 | .12 | 43 | -.29 | .12 | 159 | -.13 | .21 | |
| +age+n-3/n-6 | 44 | .24 | .15 | 38 | -.02 | .94 | 34 | -.24 | .42 | 159 | -.14 | .17 | ||||
| Men + Womenc | ||||||||||||||||
| raw1 | 93 | -.05 | .64 | 75 | -.14 | .22 | 77 | -.22 | .06 | |||||||
| +age | 93 | -.07 | .58 | 75 | -.04 | .76 | ||||||||||
| +n-3/n-62 | 75 | -.06 | .66 | 75 | -.07 | .62 | ||||||||||
| +age+n-3/n-6 | 82 | -.21 | .25 | 75 | -.08 | .55 | 75 | -.001 | 1.00 | |||||||
| raw1 | 93 | -.10 | .34 | 75 | -.15 | .20 | ||||||||||
| +age | 93 | -.13 | .27 | 75 | -.04 | .80 | ||||||||||
| +n-3/n-62 | 75 | -.12 | .35 | 75 | -.08 | .61 | ||||||||||
| +age+n-3/n-6 | 82 | -.17 | .28 | 75 | -.14 | .29 | 75 | .01 | .93 | |||||||
| raw1 | 93 | -.09 | .42 | 75 | -.15 | .21 | ||||||||||
| +age | 93 | -.11 | .35 | 75 | -.04 | .80 | ||||||||||
| +n-3/n-62 | 75 | -.10 | .43 | 75 | -.07 | .62 | ||||||||||
| +age+n-3/n-6 | 82 | -.19 | .28 | 75 | -.13 | .35 | 75 | .011 | .95 | |||||||
The analyses were performed on ln transformed data with AhRcomp as dependent and POPs as independent variables before and upon adjusted for the potential confounders.
1: non-adjusted data.
2: ratio of n-3 to n-6 fatty acids in serum.
a: Combining districts is not allowed according to the multiple regression analyses.
b: Combining districts is allowed according to the multiple regression analyses.
c: Combining districts and sex is not allowed according to the multiple regression analyses.
For Σ PCB_14, Σ pesticide and Σ POP and AhRcomp, see the legend of Table 2 and Table 3.
The Pearson correlation coefficients of serum AhR-TEQ/AhRcomp and life style factors
| Men | Women | Men + Women | ||||||||||||||||
| AhR-TEQ | AhRcomp | AhR-TEQ | AhRcomp | AhR-TEQ | AhRcomp | |||||||||||||
| n | r | p | n | r | p | n | r | p | n | r | p | n | r | p | n | r | p | |
| age | 20 | -.08 | .74 | 37 | -.02 | .91 | 11 | .12 | .72 | 44 | -.13 | .41 | 32 | -.19 | .28 | |||
| n-3/n-6 | 20 | -.01 | .97 | 37 | -.02 | .91 | 11 | -.32 | .32 | 32 | -.26 | .15 | ||||||
| BMI | 19 | .40 | .08 | 35 | . 24 | .15 | 11 | .07 | .84 | 42 | -.19 | .22 | 31 | .13 | .48 | 78 | -.17 | .14 |
| smoking | 19 | .04 | .86 | 32 | .12 | .52 | 8 | .56 | .15 | 34 | .22 | .21 | 27 | .13 | .53 | 66 | -.22 | .08 |
| seabird | 19 | .001 | 1.0 | 34 | .01 | .94 | 8 | -.47 | .20 | 37 | -.09 | .56 | 28 | -.19 | .32 | |||
| diary food | 20 | -.26 | .25 | 36 | -.12 | .48 | 11 | .34 | .29 | 44 | .014 | .93 | 32 | .03 | .85 | 81 | .19 | .09 |
| age | 50 | -.21 | .14 | 31 | .08 | .65 | 41 | .21 | .18 | 73 | -.18 | .12 | 92 | .01 | .91 | |||
| n-3/n-6 | 29 | -.06 | .75 | 36 | -.31 | .06 | 27 | .21 | .28 | 37 | .29 | .07 | 57 | -.10 | .48 | 74 | .08 | .55 |
| BMI | 41 | -.05 | .76 | 50 | -.16 | .28 | 41 | -.18 | .27 | 73 | .19 | .10 | 92 | -.16 | .14 | |||
| smoking | 43 | -.12 | .44 | 29 | .11 | .56 | 33 | .01 | .94 | 64 | -.15 | .22 | 76 | -.03 | .78 | |||
| seabird | 38 | -.01 | .97 | 46 | -.12 | .43 | 28 | -.17 | .38 | 38 | -.05 | .74 | 67 | -.05 | .72 | 85 | -.12 | .28 |
| diary food | 40 | .15 | .37 | 49 | .06 | .69 | 30 | -.003 | .99 | 40 | .23 | .15 | 71 | .09 | .44 | 90 | .14 | .18 |
| age | 37 | -.28 | .08 | 42 | -.11 | .48 | 31 | -.33 | .07 | 78 | -.21 | .66 | ||||||
| n-3/n-6 | 37 | -.002 | .99 | 42 | -.16 | .30 | 35 | -.06 | .74 | 69 | -.17 | .15 | 78 | -.11 | .31 | |||
| BMI | 37 | -.02 | .49 | 42 | -.08 | .60 | 31 | -.11 | .54 | 35 | .04 | .83 | 69 | -.13 | .28 | 78 | -.02 | .87 |
| smoking | 33 | -.12 | .49 | 37 | -.12 | .49 | 29 | -.23 | .22 | 62 | -.20 | .12 | 70 | -.21 | .08 | |||
| seabird | 35 | -.19 | .27 | 30 | -.05 | .81 | 34 | -.23 | .19 | 66 | -.01 | .37 | 74 | -.28 | .17 | |||
| diary food | 37 | -.02 | .91 | 42 | .15 | .34 | 29 | -.01 | .96 | 35 | .14 | .42 | 67 | .001 | .99 | 76 | .14 | .22 |
| age | 37 | -.19 | .25 | 37 | .05 | .76 | 43 | .04 | .81 | 43 | .10 | .53 | 81 | -.07 | .54 | 81 | .03 | .76 |
| n-3/n-6 | 37 | .26 | .12 | 37 | .01 | .95 | 43 | .12 | .90 | 43 | .02 | .91 | 81 | .12 | .28 | 81 | .007 | .95 |
| BMI | 37 | -.002 | .91 | 37 | -.002 | .99 | 43 | -.27 | .08 | 43 | -.08 | .60 | 81 | -.19 | .10 | 81 | -.07 | .52 |
| smoking | 33 | .01 | .97 | 33 | -.003 | .99 | 41 | .06 | .72 | 41 | .05 | .75 | 74 | .03 | .79 | 74 | .02 | .90 |
| seabird | na | na | na | na | na | na | na | na | na | na | na | na | na | na | na | na | na | na |
| diary food | na | na | na | na | na | na | na | na | na | na | na | na | na | na | na | na | na | na |
| age | 119 | -.09 | .34 | 166 | .03 | .66 | ||||||||||||
| n-3/n-6 | 126 | .10 | .27 | 115 | -.12 | .19 | 162 | -.04 | .59 | 242 | -.02 | .81 | ||||||
| BMI | 137 | -.02 | .86 | 167 | -.01 | .77 | 119 | .01 | .87 | 164 | -.02 | .23 | 257 | -.01 | .93 | 332 | -.09 | .10 |
| smoking | 120 | -.17 | .07 | 107 | -.01 | .96 | 141 | .04 | .68 | 227 | -.11 | .11 | 286 | -.11 | .06 | |||
| seabird* | 94 | -.07 | .47 | 68 | -.20 | .10 | 111 | -.13 | .16 | 163 | -.12 | .12 | ||||||
| diary food* | 99 | .13 | .18 | 129 | .02 | .79 | 72 | .21 | .08 | 119 | .13 | .15 | 249 | .11 | .08 | |||
na: not available
*: For the combined data of Nuuk, Sisimiut and Qaanaaq.